ABSTRACT

Fact Sheet for Healthcare Providers Lumiradx UK Ltd., LumiraDx SARS-CoV-2 RNA STAR Complete   [open pdf - 158KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the LumiraDx SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] RNA [Ribonucleic acid] STAR [Spliced Transcripts Alignment to a Reference] Complete. The LumiraDx SARS-CoV-2 RNA STAR Complete is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider."

Publisher:
Date:
2021-02-09
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations